Advertisement
Screener

T2 Biosystems, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

T2 Biosystems, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

T2 Biosystems, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$32.61 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.

Financial Statements › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2024-11-14

  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$10.12M.
  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$8.96M.
  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$13.53M.
  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$10.34M.
  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$50.08M.
  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$62.00M.
  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$49.24M.
  • T2 Biosystems, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$46.80M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month
2024-09-30-$10.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$19.08M
derived: sum of 2 quarters · filed 2024-11-14
-$32.61M
10-Q · filed 2024-11-14
-$42.95M
derived: sum of 4 quarters · filed 2024-11-14
2024-06-30-$8.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$22.50M
10-Q · filed 2024-08-08
-$32.84M
derived: sum of 3 quarters · filed 2024-08-08
-$48.26M
derived: sum of 4 quarters · filed 2024-11-14
2024-03-31-$13.53M
10-Q · filed 2024-05-06
-$23.87M
derived: sum of 2 quarters · filed 2024-05-06
-$39.30M
derived: sum of 3 quarters · filed 2024-11-14
-$45.65M
derived: sum of 4 quarters · filed 2024-11-14
2023-12-31-$10.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$25.77M
derived: sum of 2 quarters · filed 2024-11-14
-$32.11M
derived: sum of 3 quarters · filed 2024-11-14
-$50.08M
10-K · filed 2024-04-01
2023-09-30-$15.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$21.77M
derived: sum of 2 quarters · filed 2024-11-14
-$39.74M
10-Q · filed 2024-11-14
-$49.84M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$6.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$24.31M
10-Q · filed 2024-08-08
-$34.41M
derived: sum of 3 quarters · filed 2024-08-08
-$51.79M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$17.96M
10-Q · filed 2024-05-06
-$28.06M
derived: sum of 2 quarters · filed 2024-05-06
-$45.44M
derived: sum of 3 quarters · filed 2024-05-06
-$63.47M
derived: sum of 4 quarters · filed 2024-05-06
2022-12-31-$10.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$27.47M
derived: sum of 2 quarters · filed 2024-04-01
-$45.51M
derived: sum of 3 quarters · filed 2024-04-01
-$62.00M
10-K · filed 2024-04-01
2022-09-30-$17.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15
-$35.41M
derived: sum of 2 quarters · filed 2023-11-15
-$51.90M
10-Q · filed 2023-11-15
-$64.05M
derived: sum of 4 quarters · filed 2023-11-15
2022-06-30-$18.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$34.53M
10-Q · filed 2023-08-08
-$46.67M
derived: sum of 3 quarters · filed 2023-08-08
-$60.63M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$16.50M
10-Q · filed 2023-05-22
-$28.64M
derived: sum of 2 quarters · filed 2023-05-22
-$42.60M
derived: sum of 3 quarters · filed 2023-05-22
-$55.08M
derived: sum of 4 quarters · filed 2023-05-22
2021-12-31-$12.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$26.11M
derived: sum of 2 quarters · filed 2023-03-31
-$38.58M
derived: sum of 3 quarters · filed 2023-03-31
-$49.24M
10-K · filed 2023-03-31
2021-09-30-$13.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$26.44M
derived: sum of 2 quarters · filed 2022-11-14
-$37.10M
10-Q · filed 2022-11-14
-$47.01M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$12.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16
-$23.14M
10-Q · filed 2022-08-16
-$33.04M
derived: sum of 3 quarters · filed 2022-08-16
-$44.30M
derived: sum of 4 quarters · filed 2022-08-16
2021-03-31-$10.66M
10-Q · filed 2022-05-12
-$20.57M
derived: sum of 2 quarters · filed 2022-05-12
-$31.82M
derived: sum of 3 quarters · filed 2022-05-12
-$42.51M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$9.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
-$21.16M
derived: sum of 2 quarters · filed 2022-03-23
-$31.85M
derived: sum of 3 quarters · filed 2022-03-23
-$46.80M
10-K · filed 2022-03-23
2020-09-30-$11.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$21.94M
derived: sum of 2 quarters · filed 2021-11-04
-$36.89M
10-Q · filed 2021-11-04
-$50.93M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-$10.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$25.63M
10-Q · filed 2021-08-09
-$39.67M
derived: sum of 3 quarters · filed 2021-08-09
-$53.85M
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31-$14.95M
10-Q · filed 2021-05-13
-$28.99M
derived: sum of 2 quarters · filed 2021-05-13
-$43.16M
derived: sum of 3 quarters · filed 2021-05-13
-$58.81M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$14.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$28.21M
derived: sum of 2 quarters · filed 2021-03-31
-$43.86M
derived: sum of 3 quarters · filed 2021-03-31
-$59.01M
10-K · filed 2021-03-31
2019-09-30-$14.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$29.82M
derived: sum of 2 quarters · filed 2020-11-05
-$44.97M
10-Q · filed 2020-11-05
-$60.11M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$15.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
-$30.79M
10-Q · filed 2020-08-12
-$45.94M
derived: sum of 3 quarters · filed 2020-08-12
-$56.71M
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31-$15.15M
10-Q · filed 2020-05-11
-$30.30M
derived: sum of 2 quarters · filed 2020-05-11
-$41.06M
derived: sum of 3 quarters · filed 2020-05-11
-$53.39M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31-$15.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$25.92M
derived: sum of 2 quarters · filed 2020-03-16
-$38.24M
derived: sum of 3 quarters · filed 2020-03-16
-$51.15M
10-K · filed 2020-03-16
2018-09-30-$10.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-18
-$23.09M
derived: sum of 2 quarters · filed 2019-11-18
-$36.00M
10-Q · filed 2019-11-18
-$54.20M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$12.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
-$25.24M
10-Q · filed 2019-08-02
-$43.43M
derived: sum of 3 quarters · filed 2020-03-16
2018-03-31-$12.91M
10-Q · filed 2019-05-10
-$31.11M
derived: sum of 2 quarters · filed 2020-03-16
2017-12-31-$18.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$62.43M
10-K · filed 2020-03-16
2017-09-30-$44.23M
10-Q · filed 2018-11-01
2016-12-31-$54.80M
10-K · filed 2019-03-14